Effect of different ventilation methods combined with pulmonary surfactant on neonatal acute respiratory distress syndrome

Table 1 Baseline information, n (%)

Item	Research group	Control group	P value
Gestational age (d)	37.09 ± 1.12	37.67 ± 1.87	0.658
Gender
Male	20 (57.1)	19 (54.3)	0.810
Female	15 (42.9)	16 (45.7)
Birth weight (g)	3456.09 ± 866.70	3170.33 ± 767.18	0.453

Table 2 Comparison of treatment of two groups of patients (mean ± SD, n = 70)

Group	Ventilator use time (h)	Treatment time (d)	O2 treatment time (h)
Control group	83.28 ± 10.35	22.37 ± 6.63	131.47 ± 19.32
Research group	38.59 ± 8.91a	16.20 ± 4.05a	92.45 ± 10.13a

^aCompared with the control group, P < 0.05.

Table 3 Comparison of curative effects between two groups of patients [n (%), n = 70]

Group	Cure rate	Improvement rate	Case fatality rate
Control group	3 (8.6)	27 (77.1)	5 (14.3)
Research group	14 (40.0)	19 (54.3)	2 (5.7)
χ2	9.401	4.058	1.429
P value	0.002	0.044	0.232

Table 4 Comparison of chest X-ray scores and Apgar scores between two groups of patients

Group	X-ray scores		Apgar scores
	Before	After	Before	After
Control group	2.98 ± 0.42	3.45 ± 0.27	4.12 ± 0.92	6.17 ± 1.02
Research group	3.04 ± 0.39	3.98 ± 0.35a	3.96 ± 0.83	7.85 ± 0.98a

^aCompared with the control group, P < 0.05.

Table 5 Comparison of complications between the two groups [n (%), n = 70]

Group	Emphysema	Ventilator-associated pneumonia	Intraventricular hemorrhage	Patent ductus arteriosus	Total complications
Control group	4	2	3	3	13 (37.1)
Research group	2	1	1		4 (11.4)
χ2					6.293
P value					0.012